drugset / Trial / NCT00334074
Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this trial is to to determine the safety and effectiveness of therapeutic combination - Clofarabine and Cytarabine for the treatment of AML and MDS.
Timeline
- Start
- 2005-08
- Primary completion
- 2007-02
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clofarabine | Other / unclassified | 40 mg/m2 | Intravenous |
| Subject | Cytarabine | Small molecule | 1000 mg/m2 | Intravenous |